nodes	percent_of_prediction	percent_of_DWPC	metapath
Tripelennamine—CYP2D6—epilepsy syndrome	0.336	1	CbGaD
Tripelennamine—Antazoline—Phenytoin—epilepsy syndrome	0.0662	0.105	CrCrCtD
Tripelennamine—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.0556	0.088	CrCrCtD
Tripelennamine—Doxepin—Oxcarbazepine—epilepsy syndrome	0.0545	0.0862	CrCrCtD
Tripelennamine—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.0498	0.0787	CrCrCtD
Tripelennamine—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.0459	0.0726	CrCrCtD
Tripelennamine—Dimetacrine—Carbamazepine—epilepsy syndrome	0.0432	0.0684	CrCrCtD
Tripelennamine—Imipramine—Carbamazepine—epilepsy syndrome	0.0415	0.0656	CrCrCtD
Tripelennamine—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.0398	0.063	CrCrCtD
Tripelennamine—Imipramine—Oxcarbazepine—epilepsy syndrome	0.0382	0.0604	CrCrCtD
Tripelennamine—Benzphetamine—Phenytoin—epilepsy syndrome	0.0368	0.0582	CrCrCtD
Tripelennamine—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.0341	0.054	CrCrCtD
Tripelennamine—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0327	0.0517	CrCrCtD
Tripelennamine—Promazine—Carbamazepine—epilepsy syndrome	0.0324	0.0513	CrCrCtD
Tripelennamine—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.0315	0.0498	CrCrCtD
Tripelennamine—Promazine—Oxcarbazepine—epilepsy syndrome	0.0299	0.0473	CrCrCtD
Tripelennamine—Disopyramide—KCND2—epilepsy syndrome	0.000543	0.0693	CrCbGaD
Tripelennamine—Bepridil—CACNA2D2—epilepsy syndrome	0.00036	0.0459	CrCbGaD
Tripelennamine—Bepridil—CACNA1A—epilepsy syndrome	0.000341	0.0435	CrCbGaD
Tripelennamine—Tropicamide—CHRM3—epilepsy syndrome	0.000242	0.0308	CrCbGaD
Tripelennamine—Tropicamide—CHRM1—epilepsy syndrome	0.000225	0.0288	CrCbGaD
Tripelennamine—Bepridil—CACNA1H—epilepsy syndrome	0.000213	0.0271	CrCbGaD
Tripelennamine—Imipramine—KCND2—epilepsy syndrome	0.000203	0.0259	CrCbGaD
Tripelennamine—Amitriptyline—KCND2—epilepsy syndrome	0.000202	0.0257	CrCbGaD
Tripelennamine—Bepridil—CACNA1D—epilepsy syndrome	0.000201	0.0256	CrCbGaD
Tripelennamine—Amitriptyline—KCNQ3—epilepsy syndrome	0.000188	0.0239	CrCbGaD
Tripelennamine—Amitriptyline—KCNQ2—epilepsy syndrome	0.000188	0.0239	CrCbGaD
Tripelennamine—Tropicamide—CHRM2—epilepsy syndrome	0.000184	0.0235	CrCbGaD
Tripelennamine—Doxylamine—CHRM1—epilepsy syndrome	0.000184	0.0234	CrCbGaD
Tripelennamine—Amitriptyline—NTRK2—epilepsy syndrome	0.000159	0.0203	CrCbGaD
Tripelennamine—Orphenadrine—SCN9A—epilepsy syndrome	0.000156	0.0199	CrCbGaD
Tripelennamine—Disopyramide—CHRM3—epilepsy syndrome	0.000149	0.019	CrCbGaD
Tripelennamine—Orphenadrine—SCN4A—epilepsy syndrome	0.000143	0.0183	CrCbGaD
Tripelennamine—Disopyramide—CHRM1—epilepsy syndrome	0.000139	0.0178	CrCbGaD
Tripelennamine—Dimetindene—CHRM2—epilepsy syndrome	0.000131	0.0167	CrCbGaD
Tripelennamine—Dextropropoxyphene—OPRD1—epilepsy syndrome	0.000124	0.0158	CrCbGaD
Tripelennamine—Disopyramide—CHRM2—epilepsy syndrome	0.000114	0.0145	CrCbGaD
Tripelennamine—Brompheniramine—CHRM3—epilepsy syndrome	0.000111	0.0142	CrCbGaD
Tripelennamine—Orphenadrine—SCN1A—epilepsy syndrome	0.000105	0.0133	CrCbGaD
Tripelennamine—Brompheniramine—CHRM1—epilepsy syndrome	0.000104	0.0132	CrCbGaD
Tripelennamine—Rosiglitazone—CYP2C19—epilepsy syndrome	9.59e-05	0.0122	CrCbGaD
Tripelennamine—Dextropropoxyphene—OPRM1—epilepsy syndrome	9.47e-05	0.0121	CrCbGaD
Tripelennamine—Brompheniramine—CHRM2—epilepsy syndrome	8.45e-05	0.0108	CrCbGaD
Tripelennamine—Methadone—OPRD1—epilepsy syndrome	8.39e-05	0.0107	CrCbGaD
Tripelennamine—Doxepin—CHRM3—epilepsy syndrome	7.17e-05	0.00915	CrCbGaD
Tripelennamine—Rosiglitazone—CYP2D6—epilepsy syndrome	7.11e-05	0.00907	CrCbGaD
Tripelennamine—Mepyramine—CYP2D6—epilepsy syndrome	7.06e-05	0.009	CrCbGaD
Tripelennamine—Doxepin—CHRM1—epilepsy syndrome	6.69e-05	0.00854	CrCbGaD
Tripelennamine—Amitriptyline—OPRD1—epilepsy syndrome	6.52e-05	0.00832	CrCbGaD
Tripelennamine—Methadone—OPRM1—epilepsy syndrome	6.42e-05	0.00819	CrCbGaD
Tripelennamine—Aprindine—CYP2D6—epilepsy syndrome	6.38e-05	0.00814	CrCbGaD
Tripelennamine—Promazine—CHRM3—epilepsy syndrome	6.38e-05	0.00813	CrCbGaD
Tripelennamine—Carbinoxamine—CYP2C19—epilepsy syndrome	6.02e-05	0.00768	CrCbGaD
Tripelennamine—Benzphetamine—ADRA2A—epilepsy syndrome	6e-05	0.00765	CrCbGaD
Tripelennamine—Promazine—CHRM1—epilepsy syndrome	5.95e-05	0.00759	CrCbGaD
Tripelennamine—Cyclobenzaprine—HTR2A—epilepsy syndrome	5.93e-05	0.00757	CrCbGaD
Tripelennamine—Phenoxybenzamine—ADRA2A—epilepsy syndrome	5.73e-05	0.00731	CrCbGaD
Tripelennamine—Diphenhydramine—CHRM2—epilepsy syndrome	5.63e-05	0.00718	CrCbGaD
Tripelennamine—Imipramine—CHRM3—epilepsy syndrome	5.58e-05	0.00712	CrCbGaD
Tripelennamine—Amitriptyline—CHRM3—epilepsy syndrome	5.55e-05	0.00708	CrCbGaD
Tripelennamine—Doxepin—CHRM2—epilepsy syndrome	5.46e-05	0.00697	CrCbGaD
Tripelennamine—Cyclobenzaprine—CYP2D6—epilepsy syndrome	5.43e-05	0.00692	CrCbGaD
Tripelennamine—Chlorphenamine—SLC6A4—epilepsy syndrome	5.4e-05	0.00689	CrCbGaD
Tripelennamine—Orphenadrine—CHRM2—epilepsy syndrome	5.32e-05	0.00679	CrCbGaD
Tripelennamine—Rosiglitazone—ALB—epilepsy syndrome	5.32e-05	0.00679	CrCbGaD
Tripelennamine—Brompheniramine—CYP2C19—epilepsy syndrome	5.22e-05	0.00665	CrCbGaD
Tripelennamine—Imipramine—CHRM1—epilepsy syndrome	5.21e-05	0.00664	CrCbGaD
Tripelennamine—Amitriptyline—CHRM1—epilepsy syndrome	5.17e-05	0.0066	CrCbGaD
Tripelennamine—Amitriptyline—OPRM1—epilepsy syndrome	4.99e-05	0.00637	CrCbGaD
Tripelennamine—Tamoxifen—ABCC2—epilepsy syndrome	4.87e-05	0.00621	CrCbGaD
Tripelennamine—Promazine—CHRM2—epilepsy syndrome	4.86e-05	0.00619	CrCbGaD
Tripelennamine—Doxepin—ADRA2A—epilepsy syndrome	4.66e-05	0.00595	CrCbGaD
Tripelennamine—Carbinoxamine—CYP2D6—epilepsy syndrome	4.46e-05	0.00569	CrCbGaD
Tripelennamine—Tamoxifen—ABCG2—epilepsy syndrome	4.3e-05	0.00549	CrCbGaD
Tripelennamine—Imipramine—CHRM2—epilepsy syndrome	4.25e-05	0.00542	CrCbGaD
Tripelennamine—Imipramine—HTR7—epilepsy syndrome	4.23e-05	0.0054	CrCbGaD
Tripelennamine—Amitriptyline—CHRM2—epilepsy syndrome	4.22e-05	0.00539	CrCbGaD
Tripelennamine—Amitriptyline—HTR7—epilepsy syndrome	4.2e-05	0.00536	CrCbGaD
Tripelennamine—Promazine—ADRA2A—epilepsy syndrome	4.14e-05	0.00529	CrCbGaD
Tripelennamine—Bepridil—CYP2D6—epilepsy syndrome	3.94e-05	0.00503	CrCbGaD
Tripelennamine—Brompheniramine—CYP2D6—epilepsy syndrome	3.87e-05	0.00493	CrCbGaD
Tripelennamine—Chlorphenamine—CYP2D6—epilepsy syndrome	3.8e-05	0.00484	CrCbGaD
Tripelennamine—Dextropropoxyphene—CYP2D6—epilepsy syndrome	3.67e-05	0.00468	CrCbGaD
Tripelennamine—Amitriptyline—ADRA2A—epilepsy syndrome	3.61e-05	0.0046	CrCbGaD
Tripelennamine—Doxepin—SLC6A4—epilepsy syndrome	3.56e-05	0.00454	CrCbGaD
Tripelennamine—Diphenhydramine—CYP2C19—epilepsy syndrome	3.47e-05	0.00443	CrCbGaD
Tripelennamine—Tamoxifen—CYP2C19—epilepsy syndrome	3.38e-05	0.00432	CrCbGaD
Tripelennamine—HRH1—Signaling Pathways—PRICKLE1—epilepsy syndrome	3.37e-05	0.00142	CbGpPWpGaD
Tripelennamine—Doxepin—CYP2C19—epilepsy syndrome	3.37e-05	0.0043	CrCbGaD
Tripelennamine—HRH1—GPCR downstream signaling—GRM8—epilepsy syndrome	3.36e-05	0.00142	CbGpPWpGaD
Tripelennamine—Methadone—CYP2C19—epilepsy syndrome	3.35e-05	0.00428	CrCbGaD
Tripelennamine—HRH1—GPCR ligand binding—BDKRB2—epilepsy syndrome	3.29e-05	0.00139	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CXCL12—epilepsy syndrome	3.29e-05	0.00139	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	3.28e-05	0.00139	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCR9—epilepsy syndrome	3.28e-05	0.00139	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—NPY2R—epilepsy syndrome	3.28e-05	0.00139	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—SSTR1—epilepsy syndrome	3.28e-05	0.00139	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCR8—epilepsy syndrome	3.28e-05	0.00139	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CNR1—epilepsy syndrome	3.23e-05	0.00136	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GRM4—epilepsy syndrome	3.22e-05	0.00136	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GRM3—epilepsy syndrome	3.22e-05	0.00136	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—OPRD1—epilepsy syndrome	3.2e-05	0.00135	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—SSTR2—epilepsy syndrome	3.16e-05	0.00133	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR7—epilepsy syndrome	3.15e-05	0.00133	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CHRM1—epilepsy syndrome	3.07e-05	0.0013	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CCR7—epilepsy syndrome	3.07e-05	0.0013	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GRM1—epilepsy syndrome	3.07e-05	0.0013	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PDYN—epilepsy syndrome	3.07e-05	0.0013	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GRM8—epilepsy syndrome	3.05e-05	0.00129	CbGpPWpGaD
Tripelennamine—Promazine—CYP2C19—epilepsy syndrome	3e-05	0.00382	CrCbGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	2.96e-05	0.00125	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ACKR4—epilepsy syndrome	2.95e-05	0.00125	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—OPRD1—epilepsy syndrome	2.91e-05	0.00123	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GNAO1—epilepsy syndrome	2.91e-05	0.00123	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	2.9e-05	0.00122	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GAL—epilepsy syndrome	2.89e-05	0.00122	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GRM5—epilepsy syndrome	2.86e-05	0.00121	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CHRM3—epilepsy syndrome	2.86e-05	0.00121	CbGpPWpGaD
Tripelennamine—Bepridil—ABCB1—epilepsy syndrome	2.82e-05	0.00359	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—CHRM1—epilepsy syndrome	2.79e-05	0.00118	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GRM1—epilepsy syndrome	2.79e-05	0.00118	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PDYN—epilepsy syndrome	2.79e-05	0.00118	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCR7—epilepsy syndrome	2.79e-05	0.00118	CbGpPWpGaD
Tripelennamine—Imipramine—SLC6A4—epilepsy syndrome	2.77e-05	0.00353	CrCbGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	2.75e-05	0.00116	CbGpPWpGaD
Tripelennamine—Amitriptyline—SLC6A4—epilepsy syndrome	2.75e-05	0.00351	CrCbGaD
Tripelennamine—Doxepin—HTR2A—epilepsy syndrome	2.73e-05	0.00349	CrCbGaD
Tripelennamine—HRH1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	2.69e-05	0.00113	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CHRM2—epilepsy syndrome	2.69e-05	0.00113	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SSTR5—epilepsy syndrome	2.67e-05	0.00113	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SSTR4—epilepsy syndrome	2.67e-05	0.00113	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—AVP—epilepsy syndrome	2.66e-05	0.00112	CbGpPWpGaD
Tripelennamine—Imipramine—CYP2C19—epilepsy syndrome	2.62e-05	0.00335	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—GAL—epilepsy syndrome	2.62e-05	0.00111	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PDXK—epilepsy syndrome	2.62e-05	0.00111	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GLUD1—epilepsy syndrome	2.62e-05	0.00111	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—L2HGDH—epilepsy syndrome	2.62e-05	0.00111	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ADK—epilepsy syndrome	2.62e-05	0.00111	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—FAR1—epilepsy syndrome	2.62e-05	0.00111	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CERS1—epilepsy syndrome	2.62e-05	0.00111	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GABBR1—epilepsy syndrome	2.61e-05	0.0011	CbGpPWpGaD
Tripelennamine—Amitriptyline—CYP2C19—epilepsy syndrome	2.61e-05	0.00333	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—GRM5—epilepsy syndrome	2.59e-05	0.00109	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CHRM3—epilepsy syndrome	2.59e-05	0.00109	CbGpPWpGaD
Tripelennamine—Diphenhydramine—CYP2D6—epilepsy syndrome	2.58e-05	0.00329	CrCbGaD
Tripelennamine—HRH1—Signaling Pathways—CCR10—epilepsy syndrome	2.56e-05	0.00108	CbGpPWpGaD
Tripelennamine—Tamoxifen—CYP2D6—epilepsy syndrome	2.51e-05	0.0032	CrCbGaD
Tripelennamine—HRH1—GPCR downstream signaling—HRH3—epilepsy syndrome	2.5e-05	0.00106	CbGpPWpGaD
Tripelennamine—Doxepin—CYP2D6—epilepsy syndrome	2.5e-05	0.00319	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—CX3CR1—epilepsy syndrome	2.49e-05	0.00105	CbGpPWpGaD
Tripelennamine—Methadone—CYP2D6—epilepsy syndrome	2.49e-05	0.00317	CrCbGaD
Tripelennamine—HRH1—GPCR downstream signaling—OPRM1—epilepsy syndrome	2.47e-05	0.00104	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CX3CL1—epilepsy syndrome	2.44e-05	0.00103	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—BDKRB1—epilepsy syndrome	2.44e-05	0.00103	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CHRM2—epilepsy syndrome	2.44e-05	0.00103	CbGpPWpGaD
Tripelennamine—Promazine—HTR2A—epilepsy syndrome	2.43e-05	0.0031	CrCbGaD
Tripelennamine—CYP2D6—Metabolism—PNPO—epilepsy syndrome	2.4e-05	0.00101	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	2.4e-05	0.00101	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	2.4e-05	0.00101	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GAMT—epilepsy syndrome	2.4e-05	0.00101	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GABBR1—epilepsy syndrome	2.37e-05	0.001	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CCR3—epilepsy syndrome	2.33e-05	0.000983	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	2.32e-05	0.000978	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HRH3—epilepsy syndrome	2.27e-05	0.00096	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—NPY—epilepsy syndrome	2.27e-05	0.000958	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	2.27e-05	0.000957	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CCR5—epilepsy syndrome	2.26e-05	0.000953	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—OPRM1—epilepsy syndrome	2.24e-05	0.000945	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GRM2—epilepsy syndrome	2.24e-05	0.000944	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—QDPR—epilepsy syndrome	2.23e-05	0.000941	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CA4—epilepsy syndrome	2.23e-05	0.000941	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	2.22e-05	0.000938	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR2A—epilepsy syndrome	2.21e-05	0.000933	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—OXT—epilepsy syndrome	2.19e-05	0.000924	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CXCL2—epilepsy syndrome	2.19e-05	0.000924	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CRH—epilepsy syndrome	2.19e-05	0.000924	CbGpPWpGaD
Tripelennamine—Imipramine—HTR2A—epilepsy syndrome	2.13e-05	0.00271	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—CCR3—epilepsy syndrome	2.11e-05	0.000893	CbGpPWpGaD
Tripelennamine—Amitriptyline—HTR2A—epilepsy syndrome	2.11e-05	0.0027	CrCbGaD
Tripelennamine—HRH1—GPCR ligand binding—AGT—epilepsy syndrome	2.1e-05	0.000885	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—COX3—epilepsy syndrome	2.1e-05	0.000885	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—NPY—epilepsy syndrome	2.06e-05	0.00087	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SSTR3—epilepsy syndrome	2.02e-05	0.000853	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—OXT—epilepsy syndrome	1.99e-05	0.000839	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCL3—epilepsy syndrome	1.99e-05	0.000839	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CXCL2—epilepsy syndrome	1.99e-05	0.000839	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CRH—epilepsy syndrome	1.99e-05	0.000839	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PFKL—epilepsy syndrome	1.99e-05	0.000839	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	1.99e-05	0.000839	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	1.99e-05	0.000839	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	1.99e-05	0.000839	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	1.99e-05	0.000839	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	1.98e-05	0.000836	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	1.98e-05	0.000836	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.98e-05	0.000835	CbGpPWpGaD
Tripelennamine—Imipramine—CYP2D6—epilepsy syndrome	1.95e-05	0.00248	CrCbGaD
Tripelennamine—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.94e-05	0.000818	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	1.94e-05	0.000818	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	1.94e-05	0.000818	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	1.94e-05	0.000818	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	1.94e-05	0.000818	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	1.94e-05	0.000818	CbGpPWpGaD
Tripelennamine—Amitriptyline—CYP2D6—epilepsy syndrome	1.93e-05	0.00247	CrCbGaD
Tripelennamine—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	1.9e-05	0.000802	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	1.9e-05	0.000802	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	1.87e-05	0.000788	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	1.87e-05	0.000788	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.86e-05	0.000786	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.86e-05	0.000786	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	1.83e-05	0.000771	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.82e-05	0.000768	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ATIC—epilepsy syndrome	1.82e-05	0.000767	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—UPB1—epilepsy syndrome	1.82e-05	0.000767	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NEU1—epilepsy syndrome	1.82e-05	0.000767	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	1.8e-05	0.000761	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PGF—epilepsy syndrome	1.8e-05	0.000761	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	1.8e-05	0.000759	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—SST—epilepsy syndrome	1.8e-05	0.000759	CbGpPWpGaD
Tripelennamine—Tamoxifen—ABCB1—epilepsy syndrome	1.79e-05	0.00228	CrCbGaD
Tripelennamine—Doxepin—ABCB1—epilepsy syndrome	1.79e-05	0.00228	CrCbGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	1.78e-05	0.000752	CbGpPWpGaD
Tripelennamine—Methadone—ABCB1—epilepsy syndrome	1.78e-05	0.00227	CrCbGaD
Tripelennamine—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	1.76e-05	0.000745	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.76e-05	0.000743	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	1.75e-05	0.000738	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	1.73e-05	0.000729	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	1.72e-05	0.000726	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	1.72e-05	0.000726	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	1.7e-05	0.000717	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.69e-05	0.000714	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	1.69e-05	0.000714	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GBE1—epilepsy syndrome	1.69e-05	0.000713	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	1.69e-05	0.000713	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	1.66e-05	0.0007	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	1.65e-05	0.000698	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	1.65e-05	0.000696	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	1.65e-05	0.000696	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	1.65e-05	0.000696	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	1.65e-05	0.000696	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	1.62e-05	0.000683	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	1.59e-05	0.00067	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.57e-05	0.000663	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.55e-05	0.000654	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GAL—epilepsy syndrome	1.55e-05	0.000654	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	1.55e-05	0.000654	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	1.55e-05	0.000652	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	1.54e-05	0.000651	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	1.53e-05	0.000647	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	1.53e-05	0.000647	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	1.53e-05	0.000647	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NT5E—epilepsy syndrome	1.51e-05	0.000636	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALAD—epilepsy syndrome	1.51e-05	0.000636	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	1.5e-05	0.000633	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.47e-05	0.00062	CbGpPWpGaD
Tripelennamine—Amitriptyline—ALB—epilepsy syndrome	1.45e-05	0.00185	CrCbGaD
Tripelennamine—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	1.44e-05	0.000608	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.44e-05	0.000608	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.44e-05	0.000608	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.44e-05	0.000606	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.44e-05	0.000606	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	1.41e-05	0.000594	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.41e-05	0.000593	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	1.4e-05	0.000592	CbGpPWpGaD
Tripelennamine—Imipramine—ABCB1—epilepsy syndrome	1.39e-05	0.00177	CrCbGaD
Tripelennamine—Amitriptyline—ABCB1—epilepsy syndrome	1.38e-05	0.00176	CrCbGaD
Tripelennamine—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.38e-05	0.000581	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	1.36e-05	0.000575	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.35e-05	0.00057	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	1.34e-05	0.000567	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.33e-05	0.00056	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	1.32e-05	0.000558	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.28e-05	0.000539	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	1.25e-05	0.000527	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.25e-05	0.000527	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.24e-05	0.000523	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NPY—epilepsy syndrome	1.22e-05	0.000514	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.22e-05	0.000514	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.2e-05	0.000508	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	1.18e-05	0.0005	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CRH—epilepsy syndrome	1.17e-05	0.000496	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	1.17e-05	0.000496	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	1.17e-05	0.000496	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	1.17e-05	0.000496	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—OXT—epilepsy syndrome	1.17e-05	0.000496	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	1.16e-05	0.000489	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.13e-05	0.000479	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.09e-05	0.000462	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	1.09e-05	0.000461	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	1.09e-05	0.000461	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.09e-05	0.00046	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.09e-05	0.00046	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	1.08e-05	0.000454	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SST—epilepsy syndrome	1.06e-05	0.000448	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	1.06e-05	0.000448	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	1.06e-05	0.000448	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	1.05e-05	0.000444	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.04e-05	0.000439	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	1.04e-05	0.000437	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	9.99e-06	0.000422	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	9.99e-06	0.000422	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	9.97e-06	0.000421	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	9.94e-06	0.00042	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	9.9e-06	0.000418	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	9.8e-06	0.000414	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	9.8e-06	0.000414	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	9.77e-06	0.000412	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	9.56e-06	0.000404	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	9.28e-06	0.000392	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	9.11e-06	0.000385	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	9.05e-06	0.000382	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	8.9e-06	0.000376	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	8.87e-06	0.000375	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	8.86e-06	0.000374	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	8.65e-06	0.000365	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	8.6e-06	0.000363	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	8.42e-06	0.000355	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	8.33e-06	0.000352	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	8.31e-06	0.000351	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	8.05e-06	0.00034	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	7.61e-06	0.000321	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	7.4e-06	0.000312	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	7.38e-06	0.000312	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	7.37e-06	0.000311	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	7.36e-06	0.000311	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	7.35e-06	0.00031	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	7.12e-06	0.0003	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	7.04e-06	0.000297	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	7.02e-06	0.000296	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	6.94e-06	0.000293	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TH—epilepsy syndrome	6.91e-06	0.000292	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	6.84e-06	0.000289	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	6.7e-06	0.000283	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	6.36e-06	0.000269	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	6.35e-06	0.000268	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	6.23e-06	0.000263	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	6.1e-06	0.000257	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	5.87e-06	0.000248	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	5.85e-06	0.000247	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	5.77e-06	0.000244	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CAT—epilepsy syndrome	5.69e-06	0.00024	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	5.54e-06	0.000234	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	5.35e-06	0.000226	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	5.23e-06	0.000221	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	5.15e-06	0.000217	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	4.73e-06	0.0002	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AGT—epilepsy syndrome	4.52e-06	0.000191	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOE—epilepsy syndrome	4.42e-06	0.000187	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	4.39e-06	0.000185	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	4.31e-06	0.000182	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	4e-06	0.000169	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	3.96e-06	0.000167	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	3.85e-06	0.000162	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—POMC—epilepsy syndrome	3.8e-06	0.00016	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	3.74e-06	0.000158	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	3.63e-06	0.000153	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.46e-06	0.000146	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	3.45e-06	0.000146	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	3.36e-06	0.000142	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.03e-06	0.000128	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	2.14e-06	9.05e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.52e-06	6.43e-05	CbGpPWpGaD
